Cargando…

SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer

Expression of the SASH1 protein is reduced in a range of human cancers and has been implicated in apoptotic cancer cell death. This study investigated whether increasing SASH1 expression could be a useful therapeutic strategy in breast cancer. Ectopic SASH1 expression increased apoptosis in 7/8 brea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burgess, Joshua T., Bolderson, Emma, Saunus, Jodi M., Zhang, Shu-Dong, Reid, Lynne E., McNicol, Anne Marie, Lakhani, Sunil R., Cuff, Katharine, Richard, Kerry, Richard, Derek J., O'Byrne, Kenneth J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341945/ https://www.ncbi.nlm.nih.gov/pubmed/27637080 http://dx.doi.org/10.18632/oncotarget.12020

Ejemplares similares

Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response
por: Burgess, Joshua T, et al.
Publicado: (2016)

SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer
por: Burgess, Joshua T., et al.
Publicado: (2020)

Molecular Aspects of Breast Cancer Metastasis to the Brain
por: Saunus, Jodi M., et al.
Publicado: (2011)

Correlation of SASH1 expression and ultrasonographic features in breast cancer
por: Gong, Xuchu, et al.
Publicado: (2017)

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
por: Saunus, Jodi M., et al.
Publicado: (2017)

The role of inner nuclear membrane proteins in tumourigenesis and as potential targets for cancer therapy
por: Rose, Maddison, et al.
Publicado: (2022)

Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2019)

Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics
por: Richard, Iain A., et al.
Publicado: (2022)

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
por: Rose, Maddison, et al.
Publicado: (2020)

Expression of MAGE‐A and NY‐ESO‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers
por: Raghavendra, Ashwini, et al.
Publicado: (2018)

In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity
por: Smart, Chanel E., et al.
Publicado: (2013)

Correction: In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity
por: Smart, Chanel E., et al.
Publicado: (2013)

Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy
por: Sobanski, Thais, et al.
Publicado: (2021)

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
por: Al-Ejeh, Fares, et al.
Publicado: (2014)

Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases
por: Lim, Malcolm, et al.
Publicado: (2022)

Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock-in mouse model
por: Xu, Zexi, et al.
Publicado: (2020)

Tumor Hypoxia Drives Genomic Instability
por: Tang, Ming, et al.
Publicado: (2021)

The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer
por: Burgess, Joshua T., et al.
Publicado: (2020)

SASH1 is Involved in an Autosomal Dominant Lentiginous Phenotype
por: Shellman, Yiqun G., et al.
Publicado: (2015)

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
por: Adwal, Alaknanda, et al.
Publicado: (2020)

Clinical Significance of SASH1 Expression in Glioma
por: Yang, Liu, et al.
Publicado: (2015)

COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis
por: Hancock, Janelle L., et al.
Publicado: (2023)

Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study
por: Kutasovic, Jamie R, et al.
Publicado: (2018)

The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin
por: Peters, Amelia A., et al.
Publicado: (2016)

The Pathology of Hereditary Breast Cancer
por: Lakhani, Sunil R.
Publicado: (1999)

Human single-stranded DNA binding proteins are essential for maintaining genomic stability
por: Ashton, Nicholas W, et al.
Publicado: (2013)

Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases—From Biology to Clinical Utility
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2022)

Chemotherapeutic Compounds Targeting the DNA Double-Strand Break Repair Pathways: The Good, the Bad, and the Promising
por: Jekimovs, Christian, et al.
Publicado: (2014)

The pathology of familial breast cancer: Morphological aspects
por: Lakhani, Sunil R
Publicado: (1999)

Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor–Positive Breast Cancer
por: Abdel-Fatah, Tarek M. A., et al.
Publicado: (2020)

A novel P53/POMC/Gαs/SASH1 autoregulatory feedback loop activates mutated SASH1 to cause pathologic hyperpigmentation
por: Zhou, Ding'an, et al.
Publicado: (2016)

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S(127)) in human breast cancers and matching brain metastases
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2020)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Expression of SASH1 in Preeclampsia and Its Effects on Human Trophoblast
por: Liu, Shisan, et al.
Publicado: (2020)

Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer
por: Rimkus, C, et al.
Publicado: (2006)

Overexpression of SASH1 Inhibits TGF-β1-Induced EMT in Gastric Cancer Cells
por: Zong, Wei, et al.
Publicado: (2016)

Rad51 supports triple negative breast cancer metastasis
por: Wiegmans, Adrian P, et al.
Publicado: (2014)

N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease
por: Shewell, Lucy K., et al.
Publicado: (2022)

Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines
por: Alexopoulou, Annika N, et al.
Publicado: (2010)

hSSB1 associates with and promotes stability of the BLM helicase
por: Croft, Laura V., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_smkbq5mtk87eprg7ng9arlcq9p